Global Colchicine Market Professional Survey Report 2019

SKU ID : QYR-14710553 | Publishing Date : 17-Sep-2019 | No. of pages : 112

Colchicine is an alkaloid extracted from the bulb of colchicum. This medicine is used to treat acute attacks of gouty arthritis and prevent acute exacerbation of recurrent gouty arthritis.
Colchicine is a highly effective drug for the treatment of acute gout, but 50% to 80% of patients taking colchicine have had gastrointestinal side effects before the onset of gout, which has affected the growth of the colchicine market.
Colchicine has been FDA approved for use in combination with probenicid for gout since 1982. As part of a program to promote safety studies for grandfathered meds, in 2009 the FDA approved its use for acute gout flares, gout prophylaxis, and Familial Mediterranean Fever. It is also used off-label for pseudogout, Behcet’s disease, pericarditis, and primary biliary cirrhosis.

The global Colchicine market was valued at 920 million US$ in 2018 and will reach 1270 million US$ by the end of 2025, growing at a CAGR of 4.0% during 2019-2025.
This report focuses on Colchicine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colchicine market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Colchicine in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Colchicine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Takeda Pharmaceuticals
Hikma
Cipla
Wockhardt
West-Ward
Excellium Pharmaceutical
Rhea Pharmaceutical
Medinova
Odan Laboratories
Prasco
Kunming Pharmaceutical
Yunnan Plant Medicine
Xishuangbanna Pharmaceutical
Guangdong Pedi
Yunnan Shan State
Tonghua Limin
Beijing Jialin Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablet
Oral Solution

Segment by Application
Acute Gout
Chronic Gout
Other Conditions

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
3500
7000

5250


  • market Reports market Reports